These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16960779)

  • 1. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
    Van Geertruyden JP; Mulenga M; Mwananyanda L; Chalwe V; Moerman F; Chilengi R; Kasongo W; Van Overmeir C; Dujardin JC; Colebunders R; Kestens L; D'Alessandro U
    J Infect Dis; 2006 Oct; 194(7):917-25. PubMed ID: 16960779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
    Shah SN; Smith EE; Obonyo CO; Kain KC; Bloland PB; Slutsker L; Hamel MJ
    J Infect Dis; 2006 Dec; 194(11):1519-28. PubMed ID: 17083036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
    Mulenga M; VangGeertruyden JP; Mwananyanda L; Chalwe V; Moerman F; Chilengi R; Van Overmeir C; Dujardin JC; D'Alessandro U
    Malar J; 2006 Aug; 5():73. PubMed ID: 16923176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi.
    Patnaik P; Jere CS; Miller WC; Hoffman IF; Wirima J; Pendame R; Meshnick SR; Taylor TE; Molyneux ME; Kublin JG
    J Infect Dis; 2005 Sep; 192(6):984-91. PubMed ID: 16107950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study.
    Kamya MR; Gasasira AF; Yeka A; Bakyaita N; Nsobya SL; Francis D; Rosenthal PJ; Dorsey G; Havlir D
    J Infect Dis; 2006 Jan; 193(1):9-15. PubMed ID: 16323126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
    Thapa S; Hollander J; Linehan M; Cox-Singh J; Bista MB; Thakur GD; Davis WA; Davis TM
    Am J Trop Med Hyg; 2007 Sep; 77(3):423-30. PubMed ID: 17827354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
    Hamel MJ; Poe A; Bloland P; McCollum A; Zhou Z; Shi YP; Ouma P; Otieno K; Vulule J; Escalante A; Udhayakumar V; Slutsker L
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.
    Mouala C; Guiguet M; Houzé S; Damond F; Pialoux G; Viget N; Costagliola D; Le Bras J; Matheron S;
    AIDS; 2009 Sep; 23(15):1997-2004. PubMed ID: 19654499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria.
    Sowunmi A; Gbotosho GO; Happi CT; Adedeji AA; Fehintola FA; Folarin OA; Tambo E; Fateye BA
    Am J Trop Med Hyg; 2007 Aug; 77(2):235-41. PubMed ID: 17690392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of severe malaria in HIV-infected adults in South Africa.
    Cohen C; Karstaedt A; Frean J; Thomas J; Govender N; Prentice E; Dini L; Galpin J; Crewe-Brown H
    Clin Infect Dis; 2005 Dec; 41(11):1631-7. PubMed ID: 16267737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
    Fanello CI; Karema C; van Doren W; Van Overmeir C; Ngamije D; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):344-50. PubMed ID: 17005222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
    Naniche D; Lahuerta M; Bardaji A; Sigauque B; Romagosa C; Berenguera A; Mandomando I; David C; Sanz S; Aponte J; Ordi J; Alonso P; Menendez C
    HIV Med; 2008 Oct; 9(9):757-64. PubMed ID: 18651857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial.
    Faucher JF; Aubouy A; Adeothy A; Cottrell G; Doritchamou J; Gourmel B; Houzé P; Kossou H; Amedome H; Massougbodji A; Cot M; Deloron P
    J Infect Dis; 2009 Jul; 200(1):57-65. PubMed ID: 19469703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Dicko A; Djimde A; Guindo O; Kone M; Tolo Y; Thera MA; Sogoba M; Fofana M; Ouattara A; Sissoko M; Jansen HF; Doumbo OK
    Am J Trop Med Hyg; 2006 Oct; 75(4):630-6. PubMed ID: 17038684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 infection in patients with severe falciparum malaria in urban India.
    Khasnis AA; Karnad DR
    J Postgrad Med; 2003; 49(2):114-7. PubMed ID: 12867684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.